- Home
- BDRX vs SOBR Comparison
BDRX vs SOBR Comparison
Compare BDRX & SOBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BDRX | SOBR |
|---|---|---|
| Founded | 2000 | 2004 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Newspapers/Magazines |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2M | 2.4M |
| IPO Year | 2015 | 2008 |
Fundamental Metrics
Financial Performance| Metric | BDRX | SOBR |
|---|---|---|
| Price | $1.32 | $0.52 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 37.1K | ★ 21.2M |
| Earning Date | 09-12-2025 | 04-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 103.55 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $437,421.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 105.62 |
| 52 Week Low | $0.60 | $0.35 |
| 52 Week High | $11.88 | $3.95 |
Technical Indicators
Market Signals| Indicator | BDRX | SOBR |
|---|---|---|
| Relative Strength Index (RSI) | 21.74 | 43.44 |
| Support Level | $1.04 | N/A |
| Resistance Level | $1.50 | $0.94 |
| Average True Range (ATR) | 0.21 | 0.22 |
| MACD | -0.03 | -0.03 |
| Stochastic Oscillator | 33.97 | 1.41 |
Price Performance
Historical ComparisonAbout BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.
About SOBR SOBR Safe Inc.
Sobr Safe Inc is a hardware and software company. The Company integrates proprietary software, SOBRsafeTM, with its patented touch-based personal alcohol awareness tracking products, SOBRcheckTM and SOBRsure, enabling non-invasive personal alcohol awareness tracking, biometric identity verification, and qualified, real-time cloud-based, informational alerts and reporting. It operates as a single segment designed to enable customers to purchase products directly through channel partners, sales agents or through its enterprise and consumer digital channels. Currently its principal markets are located in North America.